SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : Safeguard Scientifics SFE -- Ignore unavailable to you. Want to Upgrade?


To: still learning who wrote (2467)3/29/1999 11:50:00 AM
From: michael r potter  Read Replies (1) | Respond to of 4467
 
CATP will not have a negative effect on engs., as it is not treated like TLAB. It can only have a positive effect to the extent they sell some. Now the effect on NAV and pride, is a different matter. Hard to imagine SFE selling under $20, as it is not in their nature. They would sell TLAB first. [Unfortunately IMO-so far, the action of selling TLAB and buying underperforming portfolio stocks has not worked. For one it creates a significant taxable event, and 2. The stocks bought with the reduced after tax proceeds have in general done very little, as TLAB has forged higher, a new high today.] Mike



To: still learning who wrote (2467)3/31/1999 7:10:00 AM
From: Robert Scott  Read Replies (1) | Respond to of 4467
 
I don't think earnings are that important for this company. I believe what companies they have in their portfolio and when they are coming public is much more important.